IUHSA
INO icon

Itau Unibanco Holding S.A.’s Inovio Pharmaceuticals INO Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-908
Closed -$8.94K – 559
2023
Q1 		$8.94K Hold
908
– – ﹤0.01% 457
2022
Q4 		$17K Sell
908
-222
-20% -$5.03K ﹤0.01% 406
2022
Q3 		$23K Sell
1,130
-583
-34% -$14.9K ﹤0.01% 433
2022
Q2 		$36K Buy
1,713
+1,084
+172% +$30.6K ﹤0.01% 342
2022
Q1 		$27K Hold
629
– – ﹤0.01% 357
2021
Q4 		$39K Buy
629
+109
+21% +$8.73K ﹤0.01% 323
2021
Q3 		$45K Buy
520
+179
+52% +$18K ﹤0.01% 277
2021
Q2 		$38K Buy
+341
New +$32.8K ﹤0.01% 232

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Itau Unibanco Holding S.A.'s INO Position: Q2 2023 in Review

Itau Unibanco Holding S.A. sold out of Inovio Pharmaceuticals (INO) in Q2 2023, closing a stake of 908 shares — an estimated $8.94K sold.

Itau Unibanco Holding S.A. first reported a position in INO in Q2 2021 and held it in 8 quarters. The position peaked at $45K in Q3 2021. 133 funds tracked by Wall St. Rank hold INO as of Q2 2023.

  • Itau Unibanco Holding S.A. reported no remaining Inovio Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 908 Inovio Pharmaceuticals shares in Q2 2023, an estimated $8.94K.
  • Itau Unibanco Holding S.A. first reported a position in Inovio Pharmaceuticals in Q2 2021 and held it in 8 quarters.
  • Itau Unibanco Holding S.A.'s Inovio Pharmaceuticals position peaked at $45K in Q3 2021.
  • 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2023.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2023, filed 14 Aug 2023.